申请人:Schering Aktiengesellschaft
公开号:US05219862A1
公开(公告)日:1993-06-15
Compounds of formula I ##STR1## in which R.sup.2 means optionally substituted C.sub.1-7 alkyl, C.sub.2-7 alkenyl, CH.sub.2 --O--C.sub.1-4 alkyl or CH.sub.2 --S--C.sub.1-4 alkyl R.sup.6 means C.sub.2-6 alkyl, C.sub.3-6 alkenyl or C.sub.3-5 -cycloalkyl-C.sub.1-2 alkyl and R.sup.8 means CH.sub.2 --X, ##STR2## in which X stands for CN, OCH.sub.3, SCH.sub.3 or CONH.sub.2 and R.sup.1 stands for hydrogen, halogen, methyl or methoxy, and R.sup.3 and R.sup.4 each mean C.sub.1-4 alkyl or (CH.sub.2).sub.n --N(CH.sub.3).sub.2, in which n=1-4, and their acid addition salts, the process for their production, their use as pharmaceutical agents as well as intermediate compounds are described.
化学式I的化合物中,R.sup.2代表可选择取代的C.sub.1-7烷基,C.sub.2-7烯基,CH.sub.2--O--C.sub.1-4烷基或CH.sub.2--S--C.sub.1-4烷基;R.sup.6代表C.sub.2-6烷基,C.sub.3-6烯基或C.sub.3-5-环烷基-C.sub.1-2烷基;R.sup.8代表CH.sub.2--X;其中X代表CN,OCH.sub.3,SCH.sub.3或CONH.sub.2;R.sup.1代表氢,卤素,甲基或甲氧基;R.sup.3和R.sup.4各自代表C.sub.1-4烷基或(CH.sub.2).sub.n--N(CH.sub.3).sub.2,其中n=1-4;以及它们的酸盐,其生产过程,作为药用剂的用途以及中间体化合物的描述。